Activation function 1 of progesterone receptor is required for mammary development and regulation of RANKL during pregnancy

Progesterone receptor (PGR) is a member of the nuclear receptor superfamily of transcription factors. It is critical for mammary stem cells expansion, mammary ductal branching and alveologenesis. The transcriptional activity of PGR is mainly mediated by activation functions AF1 and AF2. Although the discovery of AF1 and AF2 propelled the understanding of the mechanism of gene regulation by nuclear receptors, their physiological roles are still poorly understood. This is largely due to the lack of suitable genetic models. The present study reports gain or loss of AF1 function mutant mouse models in the study of mammary development. The gain of function mutant AF1_QQQ exhibits hyperactivity while the loss of function mutant AF1_FFF shows hypoactivity on mammary development. However, the involvement of AF1 is context dependent. Whereas the AF1_FFF mutation causes significant impairment in mammary development during pregnancy or in response to estrogen and progesterone, it has no effect on mammary development in nulliparous mice. Furthermore, Rankl, but not Wnt4 and Areg is a major target gene of AF1. In conclusion, PGR AF1 is a pivotal ligand-dependent activation domain critical for mammary development during pregnancy and it exerts gene specific effect on PGR regulated genes.

Automated summary

This study reveals the crucial role of the activation function AF1 of progesterone receptor (PGR) in mammary development. Gain of function mutant AF1_QQQ shows hyperactivity while loss of function mutant AF1_FFF exhibits hypoactivity on mammary development. AF1_FFF mutation significantly impairs mammary development in response to estrogen and progesterone and during pregnancy, but has no effect on mammary development in nulliparous mice. Furthermore, Rankl is identified as a major target gene of AF1.